CPhI Biopharma News

May 17, 2018
By BioPharm International Editors
Internationalization and regulatory reform are driving growth and investment China.
Apr 11, 2018
By BioPharm International Editors
Serialization technology and implementation expert Rick Seibert will present an insight briefing on recent serialization challenges at CPhI North America in Philadelphia, PA.
Apr 11, 2018
By BioPharm International Editors
David Weingarten, PhD, and Mark Feldstein, PhD, will present ways to optimize pharma patent protection to avoid generic competition and increase return on investment at CPhI North America 2018.
Apr 10, 2018
By BioPharm International Editors
Pharma event announces plans to alternate locations between Indonesia and Thailand to open new market opportunities.
Apr 06, 2018
By BioPharm International Editors
On Tuesday, April 24, 2018, Evan Boswell, senior principal scientist at Pfizer CentreOne Contract Manufacturing, Pfizer CentreOne will give a presentation on scaling up the manufacturing process of active pharmaceutical ingredients at CPhI North America in Philadelphia, PA.
Apr 06, 2018
By BioPharm International Editors
Shashank Upadhye, Esq., managing partner at Amin Talati Upadhye, will discuss intellectual property/patent issues for active pharmaceutical ingredients and abbreviated new drug applications at CPhI North America in Philadelphia, PA, on Tuesday, April 24, 2018.
Apr 06, 2018
By BioPharm International Editors
CPhI North America 2018 is hosting a forum for female pharmaceutical professionals to network, collaborate, and share their perspectives at this year’s conference.
Mar 27, 2018
By BioPharm International Editors
Major countries will be ranked based on the potential for biopharma market growth, innovation, and competitiveness.
Feb 07, 2018
By BioPharm International Editors
CPhI North America 2018, taking place Apr. 24-26 in Philadelphia, PA, has announced Dr. Bertalan Mesko as its first keynote speaker.
Feb 07, 2018
Sponsored Content
As Europe's growing biomanufacturing and bioprocessing industries develop, now a crucial time for the small-molecule and biopharma industries to integrate in order to facilitate growth.
native1_300x100
lorem ipsum